-+ 0.00%
-+ 0.00%
-+ 0.00%

HELUS PHARMA COMPLETES ENROLLMENT IN PHASE 3 APPROACH STUDY OF HLP003 IN ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER AHEAD OF SCHEDULE

Reuters·07/21/2026 14:55:11

Please log in to view news